利民股份(002734) - 2022 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2022 was ¥1,233,401,008.19, representing a 6.25% increase year-over-year[5] - Net profit attributable to shareholders for Q3 2022 was ¥27,682,864.86, a 22.00% increase compared to the same period last year[5] - The basic earnings per share for Q3 2022 was ¥0.07, reflecting a 16.67% increase year-over-year[5] - In Q3 2022, the company achieved operating revenue of CNY 1.233 billion, a year-on-year increase of 6.25%[13] - The net profit attributable to shareholders in Q3 2022 was CNY 27.68 million, representing a 22% increase year-on-year[14] - However, for the first nine months, the net profit attributable to shareholders decreased by 33.69% to CNY 179 million, primarily due to logistics disruptions and rising raw material costs[14] - Total operating revenue for the third quarter of 2022 reached CNY 4,042,093,577.37, an increase of 9.2% compared to CNY 3,701,281,699.85 in the same period last year[20] - Net profit for the third quarter was CNY 184,918,304.21, a decrease of 36.8% from CNY 292,207,347.02 in the previous year[21] Assets and Liabilities - The total assets at the end of the reporting period reached ¥7,876,262,688.84, marking a 14.43% increase from the end of the previous year[5] - The company's total assets increased to CNY 7,876,262,688.84, compared to CNY 6,883,292,562.29 at the end of the previous year, reflecting a growth of 14.4%[19] - Current liabilities rose to CNY 3,694,169,280.94, an increase of 29.9% from CNY 2,846,889,618.25 year-on-year[19] - Long-term borrowings increased to CNY 429,960,000.00, compared to CNY 225,000,000.00 in the previous year, marking a growth of 91.1%[19] - The total liabilities of the company reached CNY 5,087,843,910.87, an increase of 27.1% from CNY 4,004,332,993.18 in the previous year[19] - The equity attributable to shareholders of the parent company was CNY 2,742,273,435.39, up from CNY 2,701,468,431.73 year-on-year, reflecting a growth of 1.5%[19] Cash Flow - The cash flow from operating activities showed a significant increase of 255.72%, totaling ¥381,653,409.53[5] - The net cash flow from operating activities for the first nine months was CNY 382 million, an increase of CNY 627 million year-on-year[14] - Net cash flow from operating activities was CNY 381,653,409.53, compared to a negative cash flow of CNY -245,085,620.65 in the previous period[25] - Cash inflow from operating activities totaled CNY 3,182,234,629.72, up from CNY 2,528,757,883.50 in the previous period[25] - Cash outflow from investing activities was CNY 1,566,044,922.18, compared to CNY 942,047,039.40 in the previous period[25] - Net cash flow from financing activities was CNY 561,099,301.25, down from CNY 995,865,505.58 in the previous period[25] - The ending balance of cash and cash equivalents was CNY 597,984,823.15, down from CNY 767,349,882.32 in the previous period[25] - The company received CNY 432,650,000.00 from investment recoveries, significantly higher than CNY 168,000,000.00 in the previous period[25] - The company paid CNY 465,034,117.44 in employee compensation, an increase from CNY 425,801,470.52 in the previous period[25] - The company reported a total cash inflow from financing activities of CNY 1,789,787,386.30, compared to CNY 1,898,330,000.00 in the previous period[25] Investments and Projects - The company's investment income decreased by 62.30% due to a decline in profits from associated companies[9] - The accounts receivable increased by 140.78%, primarily due to delayed payments[9] - The company reported a 36.79% increase in notes payable, attributed to an increase in bank acceptance bills[9] - The company organized 2,264 promotional activities and efficacy trials to enhance brand cultivation and promotion of core products[14] - The construction of the 5,000-ton glyphosate project was completed by September 30, 2022[15] - The company is advancing the new energy lithium salt project and the L-glyphosate project, with industrialization processes being accelerated[15] - The company plans to leverage rising prices of main products and decreasing raw material costs to enhance overall profitability in Q4 2022[15] - The company is focusing on international market expansion and product registration to drive sales growth[14] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 19,849[11] - The largest shareholder, Li Ming, holds 19.79% of the shares, with 28,580,000 shares pledged[11] Research and Development - Research and development expenses for the quarter were CNY 128,312,896.58, slightly down from CNY 133,976,717.04 in the same period last year[21] Financial Expenses - The company reported a decrease in financial expenses to CNY 11,697,349.91 from CNY 49,787,006.73 year-on-year[21] Comprehensive Income - The total comprehensive income for the period was CNY 187,268,818.12, a decrease from CNY 292,041,897.05 in the previous period[22] - Basic earnings per share decreased to CNY 0.48 from CNY 0.72 year-over-year[22]